Quality assurance in surgical oncology: The tale of the Dutch rectal cancer TME trial

Journal of Surgical Oncology

Volumn 97, Issue 1, 2008, Pages 5-7

  Den Dulk, Marcel ^a   Van De Velde, Cornelis J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL PRACTICE; CONFERENCE PAPER; HUMAN; NETHERLANDS; PRIORITY JOURNAL; QUALITY CONTROL; RECTUM CANCER; SURGICAL APPROACH; SURVIVAL RATE; TREATMENT INDICATION;

HUMANS; NEOPLASM RECURRENCE, LOCAL; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS;

EID: 38149045838     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20842     Document Type: Conference Paper

References (10)

1. Poortmans P, Kouloulias V, van Tienhoven G, et al.: Quality assurance in the EORTC randomized trial 22922/10925 investigating the role of irradiation of the internal mammary and medial supraclavicular lymph node chain works. Strahlenther Onkol 2006;182:576-582.
2. Vantongelen K, Steward W, Blackledge G, et al.: EORTC joint ventures in quality control: Treatment-related variables and data acquisition in chemotherapy trials. Eur J Cancer 1991;27:201-207.
3. McArdle CS, Hole D: Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ 1991;302:1501-1505.
4. Devereaux PJ, Bhandari M, Clarke M, et al.: Need for expertise based randomised controlled trials. BMJ 2005;330:88.
5. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997;336:980-987.
6. Peeters KC, Marijnen CAM, Nagtegaal ID, et al.: The TME Trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; in press, DOI: 10.1097/01.sla.0000257358.56863.ce.
7. Nagtegaal ID, Klein Kranenbarg E, Hermans J, et al.: Pathology data in the central databases of multicenter randomized trials need to be based on pathology reports and controlled by trained quality managers. J Clin Oncol 2000;18:1771-1779.
8. Nagtegaal ID, van de Velde CJH, van der Worp E, et al.: Macroscopic evaluation of rectal cancer resection specimen: Clinical significance of the pathologist in quality control. J Clin Oncol 2002;20:1729-1734.
9. Havenga K, Enker WE, Norstein J, et al.: Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: An international analysis of 1411 patients. Eur J Surg Oncol 1999;25:368-374.
10. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646.